The Effect of Addition of Metformin to SGLT2 In Diabetic Patients With Heart Failure With Preserved Ejection Fraction
Conditions: Heart Failure With Preserved Ejection Fraction; Diabete Type 2 Interventions: Drug: Metformin Sponsors: October University for Modern Sciences and Arts; clinical research unit, El-sheikh zayed specialized hospital - Egyptian Ministry of health Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cardiology | Diabetes | Diabetes Type 2 | Egypt Health | Endocrinology | Fortamet | Heart | Heart Failure | Hospitals | Metformin | Research | SGLT2 Inhibitors